(Q48505328)

English

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way

scientific article published on March 31, 1992

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

The anti-parkinsonian drug amantadine inhibits the N-methyl-D-aspartic acid-evoked release of acetylcholine from rat neostriatum in a non-competitive way (English)

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

author name string

J. C. Stoof

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618282

16 October 2022

J. Booij

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618282

16 October 2022

B. Drukarch

3

0000-0002-2417-8888

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618282

16 October 2022

E. C. Wolters

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618282

16 October 2022

language of work or name

0 references

publication date

1 March 1992

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

31 March 1992

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1618282

16 October 2022

full work available at URL

https://api.elsevier.com/content/article/PII:001429999290634G?httpAccept=text/xml

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

https://api.elsevier.com/content/article/PII:001429999290634G?httpAccept=text/plain

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

European Journal of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

213

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

439-443

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

Reversal of experimental parkinsonism by lesions of the subthalamic nucleus

1

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Stimulation of D-2 dopamine receptors decreases the evoked in vitro release of [3H]acetylcholine from rat neostriatum: role of K+ and Ca2+.

2

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

NMDA antagonists potentiate antiparkinsonian actions of L-dopa in monoamine-depleted rats

3

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

4

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Effect of amantadine on drug-induced parkisonism: relationship between plasma levels and effect

5

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

N-methyl-D-aspartate-type receptors mediate striatal 3H-acetylcholine release evoked by excitatory amino acids

6

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Amantadine in the Treatment of Parkinson's Disease

7

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Regulation of the activity of striatal cholinergic neurons by dopamine

8

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Dopamine: Release from the Brain in vivo by Amantadine

9

1 reference

10.1016/0014-2999(92)90634-G

https://api.crossref.org/works/10.1016/0014-2999(92)90634-G

16 October 2022

Identifiers

10.1016/0014-2999(92)90634-G

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/1618282

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48505328&oldid=1751986934"